NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice
- PMID: 19925840
- DOI: 10.1016/j.peptides.2009.11.005
NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice
Abstract
Peptide YY (PYY)(3-36), a neuropeptide Y (NPY) Y2 receptor agonist, is a powerful inhibitor of intestinal secretion. Based on this anti-secretory effect, NPY Y2 receptor agonists may be useful as novel anti-diarrheal agents, but anti-diarrheal efficacy has yet to be determined. We therefore examined the anti-diarrheal efficacy of PYY(3-36) and a selective Y2 receptor agonist, N-acetyl-[Leu28, Leu31]-NPY(24-36), in experimental mouse models of diarrhea. Intraperitoneal administration of PYY(3-36) (0.01-1mg/kg) and N-acetyl-[Leu28, Leu31]-NPY(24-36) (10mg/kg) significantly inhibited diarrhea (increase in wet fecal weight and diarrhea score) induced by dimethyl-prostaglandin E2, 5-hydroxytryptamine, and castor oil. Anti-diarrheal activities of PYY(3-36) and N-acetyl-[Leu28, Leu31]-NPY(24-36) were comparable to the effects of loperamide (1mg/kg), a widely used anti-diarrheal drug. To clarify the anti-diarrheal mechanisms of NPY Y2 receptor agonists, we investigated the effects of PYY(3-36) and N-acetyl-[Leu28, Leu31]-NPY(24-36) on intestinal fluid secretion and colonic transit. PYY(3-36) (1mg/kg) and N-acetyl-[Leu28, Leu31]-NPY(24-36) (10mg/kg) significantly reduced dimethyl-prostaglandin E2-induced intestinal fluid accumulation in conscious mice, suggesting that NPY Y2 receptor agonists inhibit diarrhea, at least in part, by reducing intestinal secretion. In addition, PYY(3-36) (0.01-1mg/kg) and N-acetyl-[Leu28, Leu31]-NPY(24-36) (10mg/kg) potently inhibited normal fecal output, suggesting that NPY Y2 receptor activation inhibits colonic motor function and NPY Y2 receptor agonists inhibit diarrhea partly by slowing colonic transit. These results indicate that NPY Y2 receptor agonists inhibit diarrhea in mice by not only reducing intestinal fluid secretion, but also slowing colonic transit, and illustrate the therapeutic potential of NPY Y2 receptor agonists as effective treatments for diarrhea.
Copyright (c) 2009 Elsevier Inc. All rights reserved.
Similar articles
-
Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.Peptides. 2009 Jul;30(7):1318-22. doi: 10.1016/j.peptides.2009.04.006. Epub 2009 Apr 23. Peptides. 2009. PMID: 19394383
-
NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.J Auton Nerv Syst. 1999 Oct 8;78(1):10-7. doi: 10.1016/s0165-1838(99)00056-9. J Auton Nerv Syst. 1999. PMID: 10589818
-
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G45-56. doi: 10.1152/ajpgi.00349.2009. Epub 2009 Nov 5. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 19892938 Free PMC article.
-
Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.Obes Surg. 2006 May;16(5):651-8. doi: 10.1381/096089206776944959. Obes Surg. 2006. PMID: 16687037 Review.
-
NPY family of hormones: clinical relevance and potential use in gastrointestinal disease.Curr Top Med Chem. 2007;7(17):1710-20. doi: 10.2174/156802607782340966. Curr Top Med Chem. 2007. PMID: 17979780 Review.
Cited by
-
Supplemental Enzyme and Probiotics on the Growth Performance and Nutrient Digestibility of Broilers Fed with a Newly Harvested Corn Diet.Animals (Basel). 2022 Sep 12;12(18):2381. doi: 10.3390/ani12182381. Animals (Basel). 2022. PMID: 36139241 Free PMC article.
-
Micellar nanomedicine of human neuropeptide Y.Nanomedicine. 2011 Aug;7(4):464-71. doi: 10.1016/j.nano.2011.01.004. Epub 2011 Jan 25. Nanomedicine. 2011. PMID: 21272667 Free PMC article.
-
Mechanisms of diarrhea.Curr Gastroenterol Rep. 2010 Aug;12(4):236-41. doi: 10.1007/s11894-010-0113-4. Curr Gastroenterol Rep. 2010. PMID: 20532705 Review.
-
Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors.Br J Pharmacol. 2011 Sep;164(2b):471-84. doi: 10.1111/j.1476-5381.2011.01401.x. Br J Pharmacol. 2011. PMID: 21457230 Free PMC article.
-
Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea.Clin Gastroenterol Hepatol. 2015 Jun;13(6):1051-7; quiz e61-2. doi: 10.1016/j.cgh.2014.07.020. Epub 2014 Jul 17. Clin Gastroenterol Hepatol. 2015. PMID: 25041862 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous